Category: Medications - Page 2

DOAC Dosing in Obesity: What Works, What Doesn’t, and What You Need to Know
Marian Andrecki 10

DOAC Dosing in Obesity: What Works, What Doesn’t, and What You Need to Know

DOACs like apixaban and rivaroxaban are safe and effective for obese patients at standard doses. Dabigatran increases bleeding risk, and edoxaban may need caution in extreme obesity. Learn what works, what doesn’t, and what guidelines say.

Read More
Warfarin and NSAIDs: The Real Risk of Bleeding You Can't Ignore
Marian Andrecki 13

Warfarin and NSAIDs: The Real Risk of Bleeding You Can't Ignore

Combining warfarin with NSAIDs doubles your risk of dangerous bleeding. Learn why naproxen and ibuprofen are especially risky, what alternatives actually work, and how to protect yourself from life-threatening side effects.

Read More
Immunosuppressant Generic Issues: Cyclosporine vs Tacrolimus Risks and Solutions
Marian Andrecki 10

Immunosuppressant Generic Issues: Cyclosporine vs Tacrolimus Risks and Solutions

Exploring the risks and challenges of generic cyclosporine and tacrolimus for transplant patients. Learn why bioequivalence issues, dosing differences, and switching protocols matter for safety and effectiveness.

Read More
How to Manage Medication Costs During Medicare Part D Coverage Gaps (Donut Hole) in 2024-2025
Marian Andrecki 12

How to Manage Medication Costs During Medicare Part D Coverage Gaps (Donut Hole) in 2024-2025

Learn how to cut prescription costs during Medicare Part D’s donut hole in 2024 before the $2,000 out-of-pocket cap eliminates it in 2025. Proven strategies for saving hundreds or thousands on meds.

Read More
SGLT2 Inhibitors for Type 2 Diabetes: What You Need to Know About Benefits and Risks
Marian Andrecki 12

SGLT2 Inhibitors for Type 2 Diabetes: What You Need to Know About Benefits and Risks

SGLT2 inhibitors help lower blood sugar and protect the heart and kidneys in type 2 diabetes, but come with risks like yeast infections and rare but serious ketoacidosis. Know who benefits most and what to watch for.

Read More
Salt Substitutes and ACE Inhibitors or ARBs: Hidden Potassium Risks
Marian Andrecki 14

Salt Substitutes and ACE Inhibitors or ARBs: Hidden Potassium Risks

Salt substitutes with potassium chloride can cause dangerous potassium buildup when taken with ACE inhibitors or ARBs, especially for people with kidney disease. Learn who’s at risk and what safer alternatives exist.

Read More
Community Health Presentations: Public Education Resources on Generic Drugs
Marian Andrecki 11

Community Health Presentations: Public Education Resources on Generic Drugs

Community health presentations are helping patients understand that generic drugs are just as safe and effective as brand-name versions-saving billions and improving adherence. Learn the facts, bust the myths, and see how public education is changing lives.

Read More
Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs
Marian Andrecki 8

Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs

States are using MAC lists, price-gouging laws, and PBM transparency rules to control Medicaid spending on generic drugs. With 85% of prescriptions being generics, these strategies save billions - but supply chain risks remain.

Read More
Why You Should Never Skip Doses: Timing Your Prescription Medication
Marian Andrecki 9

Why You Should Never Skip Doses: Timing Your Prescription Medication

Skipping prescription doses can lead to serious health risks, from antibiotic resistance to life-threatening blood pressure spikes. Learn why timing matters, how to stay on track, and what to do when you forget.

Read More
Grapefruit Juice and Medications: What You Need to Know Before You Drink
Marian Andrecki 10

Grapefruit Juice and Medications: What You Need to Know Before You Drink

Grapefruit juice can dangerously increase levels of many medications, leading to serious side effects. Learn which drugs are affected, why it happens, and what to do to stay safe.

Read More